P2Y12 Inhibitors Refill Gap Predicts Death in Medicare Beneficiaries on Chronic Dialysis.
P2Y12 抑制劑補充間隙預測接受慢性透析的 Medicare 受益者死亡。
Kidney Int Rep 2024-07-31
Care Gaps in Sodium-Glucose Cotransporter-2 Inhibitor and Renin Angiotensin System Inhibitor Prescriptions for Patients with Diabetic Kidney Disease.
糖尿病腎病患者的鈉葡萄糖共轉運子-2抑制劑和腎素-血管緊張素系統抑制劑處方中的護理缺口。
J Gen Intern Med 2023-06-15
P2Y<sub>12</sub> Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events.
P2Y<sub>12</sub> 抑制劑或阿司匹林單獨用於冠心病次級預防。
J Am Coll Cardiol 2023-12-18
Contemporary secondary prevention in survivors of ST-elevation myocardial infarction with and without chronic kidney disease: a retrospective analysis.
ST段抬高型心肌梗塞倖存者之當代次級預防:具有及不具有慢性腎臟疾病者之回顧性分析。
Clin Kidney J 2023-11-03
Long-Term Impact of Renin-Angiotensin System Inhibitors for Secondary Prevention in Patients with Chronic Kidney Disease Who Underwent Percutaneous Coronary Intervention.
慢性腎臟病患者接受經皮冠狀動脈介入治療後,腎素-血管緊張素系統抑制劑對二次預防的長期影響。
Kidney Dis (Basel) 2024-02-10
One- Versus Three-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease.
慢性腎臟疾病高出血風險患者中一個月對比三個月的雙抗血小板治療。
Am J Cardiol 2024-06-13
Acute myocardial infarction and chronic kidney disease: A nationwide cohort study on management and outcomes from 2010-2022.
急性心肌梗塞與慢性腎病:2010-2022年的全國性隊列研究管理與結果。
Clin J Am Soc Nephrol 2024-07-18
Association of kidney function with SGLT2 inhibitor discontinuation among United States Veterans.
美國退伍軍人中腎功能與 SGLT2 抑制劑停用的關聯。
Clin J Am Soc Nephrol 2024-08-21
Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Patients with CKD.
慢性腎病患者中鈉-葡萄糖共轉運蛋白-2抑制劑和類胰高血糖素肽-1受體激動劑的停用。
J Am Soc Nephrol 2024-08-26